Mobilise App IPO GMP - AstroIPO

Mobilise App IPO GMP


February 27, 2026 Written By Mihir Gohel, Reviewed and Fact Checked by Harpal Parmar

Mobilise App IPO opens for subscription on February 23, 2026, and closes on February 25, 2026, with an issue size of ₹20.10 crore entirely as a fresh issue of 25.12 lakh shares priced at ₹75 – ₹80 per share for listing on NSE SME on March 2. Noida-based Mobilise App Lab develops AI-powered sales enablement and field force automation SaaS platform serving 200+ enterprises across pharma, FMCG, and insurance sectors. Incorporated in 2019, the company offers real-time analytics, geo-fencing, and incentive management features. Mobilise App IPO targets investors in B2B SaaS growth trajectory driven by enterprise digitization.

₹5

Latest IPO GMP
Last updated on 27 Feb 2026 19.26

₹80

IPO Offer Price
*cut off price

Listing Price
Listing Date 02/03/2026

Expert Opinions

Market sentiment for Mobilise App IPO appears constructive among SaaS investors, reflecting robust FY25 profitability turnaround despite concentration risks highlighted by analysts. Company strengths include 33.88% revenue growth to ₹16.24 crore, 51.93% PAT surge to ₹4.71 crore, sticky enterprise contracts yielding 99% collections, AI-powered sales automation platform, and pharma vertical dominance.

Risks encompass 94% revenue from top 10 clients creating dependency, geographic concentration limiting scale, high customer acquisition costs, and competition from Zoho/ Freshworks suites. Valuation analysis for Mobilise App IPO and year 2025 demonstrates Return on Equity (ROE) of 57.05%, ROCE of 75.40%, and Net Asset Value (NAV) of ₹41.30, at 14.21x FY26E P/E appearing reasonably priced for growth trajectory. Long-term investment perspective benefits from digital sales transformation across SMB enterprises accelerating 25% annually.

Investor Considerations

Mobilise App IPO reflects impressive company performance and fundamentals in FY 2025, with revenue climbing 33.88% to ₹16.24 crore and PAT expanding 51.93% to ₹4.71 crore alongside 42.6% EBITDA margins from SaaS subscriptions. B2B SaaS sector outlook surges at 25% CAGR driven by enterprise digital transformation across pharma and FMCG. IPO Valuation of Financial Year 2025 for Mobilise App IPO and year indicates Price to Book Value of 1.94, PAT Margin of 29.20%, and Debt/Equity of 0.01, showcasing pristine balance sheet efficiency.

Growth prospects harness R&D investments and international expansion targeting ARR doubling annually. Risk factors include 94% revenue concentration from top clients, high customer acquisition costs, product-market fit validation, and competition from established CRM platforms. Short-term investment goals monitor listing execution amid SME volatility, while long-term horizons reward recurring revenue compounding in SMB digitization.

Mobilise App IPO GMP Trends: Day-to-Day Insight

Date GMP Trend
27 Feb 2026 19.26 ₹5 Down
26 Feb 2026 19.47 ₹7 ---
25 Feb 2026 19.32 ₹7 Down
24 Feb 2026 19.53 ₹16 ---
23 Feb 2026 19.14 ₹16 Up
22 Feb 2026 10.18 ₹00 ---
21 Feb 2026 20.48 ₹00 ---

FAQs

Mobilise App IPO Current GMP is ₹5.

Mobilise App IPO Expected Returns is 6.25%.

Mobilise App IPO estimated listing price is ₹85.

Leave a Reply

Your email address will not be published. Required fields are marked *